CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

doi:10.1084/jem.182.5.1557

This Article

	Full Text (PDF, 1219K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Schattner, E. J.
	Articles by Friedman, S. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Schattner, E. J.
	Articles by Friedman, S. M.


Social Bookmarking

	What's this?

ARTICLES

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

EJ Schattner, KB Elkon, DH Yoo, J Tumang, PH Krammer, MK Crow and SM Friedman
Department of Medicine, Hospital for Special Surgery, New York 10021, USA.

The Apo-1/Fas antigen (CD95) mediates programmed cell death of lymphocytes when bound by Fas ligand or anti-Apo-1/Fas antibody. In contrast, the CD40 antigen provides a potent activation and survival signal to B lymphocytes when it is engaged by its T cell ligand (CD40L, gp39) or cross-linked by anti-CD40 antibody. In this study, we use human tonsillar B cells and the Ramos Burkitt's lymphoma B cell line, which serves as a model for human germinal center B lymphocytes, to study the effectors of Apo-1/Fas expression and apoptosis of human B cells. We found that Apo-1/Fas expression was upregulated on both malignant and normal human B lymphocytes after CD40 ligation induced by (a) cognate T helper-B cell interaction mediated by microbial superantigen (SAg); (b) contact-dependent interaction with CD40L+, but not CD40L- Jurkat mutant T cell clones; and (c) monoclonal anti-CD40, but not any of a panel of control antibodies. Enhanced B cell Fas/Apo-1 expression is functionally significant. Coculture of Ramos Burkitt's lymphoma line cells with irradiated SAg-reactive CD4+ T cells with SAg or CD40L+ Jurkat T cells results in B cell apoptosis, evidenced by reduced cell viability and DNA laddering. This process is augmented by the addition of anti-Apo-1/Fas monoclonal antibody, consistent with an acquired susceptibility to Apo-1/Fas-mediated apoptosis. These data support an immunoregulatory pathway in which seemingly contradictory signals involving the B cell proliferation/survival antigen CD40, as well as the Apo-1/Fas molecule, which mediates programmed cell death of lymphocytes, are linked in the process of human B cell activation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Troeger, A., Glouchkova, L., Ackermann, B., Escherich, G., Meisel, R., Hanenberg, H., den Boer, M. L., Pieters, R., Janka-Schaub, G. E., Goebel, U., Laws, H.-J., Dilloo, D. (2008). High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95. Blood 112: 1028-1034 [Abstract] [Full Text]
Lee, J. K., Mathew, S. O., Vaidya, S. V., Kumaresan, P. R., Mathew, P. A. (2007). CS1 (CRACC, CD319) Induces Proliferation and Autocrine Cytokine Expression on Human B Lymphocytes. J. Immunol. 179: 4672-4678 [Abstract] [Full Text]
de Goer de Herve, M.-G., Durali, D., Tran, T.-A., Maigne, G., Simonetta, F., Leclerc, P., Delfraissy, J.-F., Taoufik, Y. (2005). Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40. Blood 106: 2806-2814 [Abstract] [Full Text]
Elzey, B. D., Grant, J. F., Sinn, H. W., Nieswandt, B., Waldschmidt, T. J., Ratliff, T. L. (2005). Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J. Leukoc. Biol. 78: 80-84 [Abstract] [Full Text]
Arens, R., Baars, P. A., Jak, M., Tesselaar, K., van der Valk, M., van Oers, M. H. J., van Lier, R. A. W. (2005). Cutting Edge: CD95 Maintains Effector T Cell Homeostasis in Chronic Immune Activation. J. Immunol. 174: 5915-5920 [Abstract] [Full Text]
Mizuno, T., Rothstein, T. L. (2005). B Cell Receptor (BCR) Cross-Talk: CD40 Engagement Enhances BCR-Induced ERK Activation. J. Immunol. 174: 3369-3376 [Abstract] [Full Text]
Basso, K., Klein, U., Niu, H., Stolovitzky, G. A., Tu, Y., Califano, A., Cattoretti, G., Dalla-Favera, R. (2004). Tracking CD40 signaling during germinal center development. Blood 104: 4088-4096 [Abstract] [Full Text]
Kokkonen, T. S., Augustin, M. T., Makinen, J. M., Kokkonen, J., Karttunen, T. J. (2004). High Endothelial Venules of the Lymph Nodes Express Fas Ligand. J. Histochem. Cytochem. 52: 693-700 [Abstract] [Full Text]
He, B., Chadburn, A., Jou, E., Schattner, E. J., Knowles, D. M., Cerutti, A. (2004). Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL. J. Immunol. 172: 3268-3279 [Abstract] [Full Text]
Mongini, P. K. A., Jackson, A. E., Tolani, S., Fattah, R. J., Inman, J. K. (2003). Role of Complement-Binding CD21/CD19/CD81 in Enhancing Human B Cell Protection from Fas-Mediated Apoptosis. J. Immunol. 171: 5244-5254 [Abstract] [Full Text]
Schram, B. R., Rothstein, T. L. (2003). NF-{kappa}B Is Required for Surface Ig-Induced Fas Resistance in B Cells. J. Immunol. 170: 3118-3124 [Abstract] [Full Text]
Pedersen, I. M., Kitada, S., Leoni, L. M., Zapata, J. M., Karras, J. G., Tsukada, N., Kipps, T. J., Choi, Y. S., Bennett, F., Reed, J. C. (2002). Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 100: 1795-1801 [Abstract] [Full Text]
Zuniga, E., Motran, C. C., Montes, C. L., Yagita, H., Gruppi, A. (2002). Trypanosoma cruzi Infection Selectively Renders Parasite-Specific IgG+ B Lymphocytes Susceptible to Fas/Fas Ligand-Mediated Fratricide. J. Immunol. 168: 3965-3973 [Abstract] [Full Text]
Tumang, J. R., Negm, R. S., Solt, L. A., Schneider, T. J., Colarusso, T. P., Hastings, W. D., Woodland, R. T., Rothstein, T. L. (2002). BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton's Tyrosine Kinase. J. Immunol. 168: 2712-2719 [Abstract] [Full Text]
Suvas, S., Singh, V., Sahdev, S., Vohra, H., Agrewala, J. N. (2002). Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma. J. Biol. Chem. 277: 7766-7775 [Abstract] [Full Text]
Dadgostar, H., Zarnegar, B., Hoffmann, A., Qin, X.-F., Truong, U., Rao, G., Baltimore, D., Cheng, G. (2002). Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc. Natl. Acad. Sci. USA 99: 1497-1502 [Abstract] [Full Text]
Martinez-Barnetche, J., Madrid-Marina, V., Flavell, R. A., Moreno, J. (2002). Does CD40 Ligation Induce B Cell Negative Selection?. J. Immunol. 168: 1042-1049 [Abstract] [Full Text]
Zhu, N., Ramirez, L. M., Lee, R. L., Magnuson, N. S., Bishop, G. A., Gold, M. R. (2002). CD40 Signaling in B Cells Regulates the Expression of the Pim-1 Kinase Via the NF-{kappa}B Pathway. J. Immunol. 168: 744-754 [Abstract] [Full Text]
Yoshikawa, H., Nakajima, Y., Tasaka, K. (2001). IFN-{gamma} Induces the Apoptosis of WEHI 279 and Normal Pre-B Cell Lines by Expressing Direct Inhibitor of Apoptosis Protein Binding Protein with Low pI. J. Immunol. 167: 2487-2495 [Abstract] [Full Text]
Besnault, L., Schrantz, N., Auffredou, M. T., Leca, G., Bourgeade, M. F., Vazquez, A. (2001). B Cell Receptor Cross-Linking Triggers a Caspase-8- Dependent Apoptotic Pathway That Is Independent of the Death Effector Domain of Fas-Associated Death Domain Protein. J. Immunol. 167: 733-740 [Abstract] [Full Text]
Catlett, I. M., Xie, P., Hostager, B. S., Bishop, G. A. (2001). Signaling Through MHC Class II Molecules Blocks CD95-Induced Apoptosis. J. Immunol. 166: 6019-6024 [Abstract] [Full Text]
Bijl, M, Horst, G, Limburg, P C, Kallenberg, C G M (2001). Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 60: 523-526 [Abstract] [Full Text]
Tian, M. T., Chou, C.-H. G., DeFranco, A. L. (2001). Apoptosis induced by the antigen receptor and Fas in a variant of the immature B cell line WEHI-231 and in splenic immature B cells. Int Immunol 13: 581-592 [Abstract] [Full Text]
Jung, G., Grosse-Hovest, L., Krammer, P. H., Rammensee, H.-G. (2001). Target Cell-restricted Triggering of the CD95 (APO-1/Fas) Death Receptor with Bispecific Antibody Fragments. Cancer Res. 61: 1846-1848 [Abstract] [Full Text]
Storz, M., Zepter, K., Kamarashev, J., Dummer, R., Burg, G., Häffner, A. C. (2001). Coexpression of CD40 and CD40 Ligand in Cutaneous T-Cell Lymphoma (Mycosis Fungoides). Cancer Res. 61: 452-454 [Abstract] [Full Text]
Annunziata, C. M., Safiran, Y. J., Irving, S. G., Kasid, U. N., Cossman, J. (2000). Hodgkin disease: pharmacologic intervention of the CD40-NFkappa B pathway by a protease inhibitor. Blood 96: 2841-2848 [Abstract] [Full Text]
Andjelic, S., Hsia, C., Suzuki, H., Kadowaki, T., Koyasu, S., Liou, H.-C. (2000). Phosphatidylinositol 3-Kinase and NF-{kappa}B/Rel Are at the Divergence of CD40-Mediated Proliferation and Survival Pathways. J. Immunol. 165: 3860-3867 [Abstract] [Full Text]
Hennino, A., Berard, M., Casamayor-Palleja, M., Krammer, P. H., Defrance, T. (2000). Regulation of the Fas Death Pathway by FLICE-Inhibitory Protein in Primary Human B Cells. J. Immunol. 165: 3023-3030 [Abstract] [Full Text]
Rifkin, I. R., Leadbetter, E. A., Beaudette, B. C., Kiani, C., Monestier, M., Shlomchik, M. J., Marshak-Rothstein, A. (2000). Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells. J. Immunol. 165: 1626-1633 [Abstract] [Full Text]
Munz, C., Bickham, K. L., Subklewe, M., Tsang, M. L., Chahroudi, A., Kurilla, M. G., Zhang, D., O'Donnell, M., Steinman, R. M. (2000). Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1. JEM 191: 1649-1660 [Abstract] [Full Text]
Yoshida, T., Higuchi, T., Hagiyama, H., Strasser, A., Nishioka, K., Tsubata, T. (2000). Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int Immunol 12: 517-526 [Abstract] [Full Text]
Urashima, M., Suzuki, H., Yuza, Y., Akiyama, M., Ohno, N., Eto, Y. (2000). An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium. Blood 95: 1258-1263 [Abstract] [Full Text]
Jalukar, S. V., Hostager, B. S., Bishop, G. A. (2000). Characterization of the Roles of TNF Receptor-Associated Factor 6 in CD40-Mediated B Lymphocyte Effector Functions. J. Immunol. 164: 623-630 [Abstract] [Full Text]
Ashany, D., Savir, A., Bhardwaj, N., Elkon, K. B. (1999). Dendritic Cells Are Resistant to Apoptosis Through the Fas (CD95/APO-1) Pathway. J. Immunol. 163: 5303-5311 [Abstract] [Full Text]
Drenou, B., Blancheteau, V., Burgess, D. H., Fauchet, R., Charron, D. J., Mooney, N. A. (1999). A Caspase-Independent Pathway of MHC Class II Antigen-Mediated Apoptosis of Human B Lymphocytes. J. Immunol. 163: 4115-4124 [Abstract] [Full Text]
Yin, D., Zhang, L., Wang, R., Radvanyi, L., Haudenschild, C., Fang, Q., Kehry, M. R., Shi, Y. (1999). Ligation of CD28 In Vivo Induces CD40 Ligand Expression and Promotes B Cell Survival. J. Immunol. 163: 4328-4334 [Abstract] [Full Text]
Catlett, I. M., Bishop, G. A. (1999). Cutting Edge: A Novel Mechanism for Rescue of B Cells from CD95/Fas-Mediated Apoptosis. J. Immunol. 163: 2378-2381 [Abstract] [Full Text]
Fernandes, D. M., Baird, A. M., Berg, L. J., Rock, K. L. (1999). A Monoclonal Antibody Reactive with a 40-kDa Molecule on Fetal Thymocytes and Tumor Cells Blocks Proliferation and Stimulates Aggregation and Apoptosis. J. Immunol. 163: 1306-1314 [Abstract] [Full Text]
Leveille, C., Zekki, H., Al-Daccak, R., Mourad, W. (1999). CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities. Int Immunol 11: 719-730 [Abstract] [Full Text]
Matsue, H., Edelbaum, D., Hartmann, A. C., Morita, A., Bergstresser, P. R., Yagita, H., Okumura, K., Takashima, A. (1999). Dendritic Cells Undergo Rapid Apoptosis In Vitro During Antigen-Specific Interaction with CD4+ T Cells. J. Immunol. 162: 5287-5298 [Abstract] [Full Text]
Henriquez, N. V., Floettmann, E., Salmon, M., Rowe, M., Rickinson, A. B. (1999). Differential Responses to CD40 Ligation Among Burkitt Lymphoma Lines That Are Uniformly Responsive to Epstein-Barr Virus Latent Membrane Protein 1. J. Immunol. 162: 3298-3307 [Abstract] [Full Text]
Buhmann, R., Nolte, A., Westhaus, D., Emmerich, B., Hallek, M. (1999). CD40-Activated B-Cell Chronic Lymphocytic Leukemia Cells for Tumor Immunotherapy: Stimulation of Allogeneic Versus Autologous T Cells Generates Different Types of Effector Cells. Blood 93: 1992-2002 [Abstract] [Full Text]
Chien, M. M., Zahradka, K. E., Newell, M. K., Freed, J. H. (1999). Fas-induced B Cell Apoptosis Requires an Increase in Free Cytosolic Magnesium as an Early Event. J. Biol. Chem. 274: 7059-7066 [Abstract] [Full Text]
Hsing, Y., Bishop, G. A. (1999). Requirement for Nuclear Factor-{kappa}B Activation by a Distinct Subset of CD40-Mediated Effector Functions in B Lymphocytes. J. Immunol. 162: 2804-2811 [Abstract] [Full Text]
Tsukamoto, N., Kobayashi, N., Azuma, S., Yamamoto, T., Inoue, J.-i. (1999). Two differently regulated nuclear factor kappa B activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA 96: 1234-1239 [Abstract] [Full Text]
Gutierrez, M. I., Cherney, B., Hussain, A., Mostowski, H., Tosato, G., Magrath, I., Bhatia, K. (1999). Bax Is Frequently Compromised in Burkitt's Lymphomas with Irreversible Resistance to Fas-induced Apoptosis. Cancer Res. 59: 696-703 [Abstract] [Full Text]
Yun, T. J., Chaudhary, P. M., Shu, G. L., Frazer, J. K., Ewings, M. K., Schwartz, S. M., Pascual, V., Hood, L. E., Clark3, E. A. (1998). OPG/FDCR-1, a TNF Receptor Family Member, Is Expressed in Lymphoid Cells and Is Up-Regulated by Ligating CD40. J. Immunol. 161: 6113-6121 [Abstract] [Full Text]
Voorzanger-Rousselot, N., Favrot, M.-C., Blay, J.-Y. (1998). Resistance to Cytotoxic Chemotherapy Induced by CD40 Ligand in Lymphoma Cells. Blood 92: 3381-3387 [Abstract] [Full Text]
Craxton, A., Shu, G., Graves, J. D., Saklatvala, J., Krebs, E. G., Clark, E. A. (1998). p38 MAPK Is Required for CD40-Induced Gene Expression and Proliferation in B Lymphocytes. J. Immunol. 161: 3225-3236 [Abstract] [Full Text]
Prasad, N. K. A., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M. D., Ruberti, G., Kaveri, S. V. (1998). Therapeutic Preparations of Normal Polyspecific IgG (IVIg) Induce Apoptosis in Human Lymphocytes and Monocytes: A Novel Mechanism of Action of IVIg Involving the Fas Apoptotic Pathway. J. Immunol. 161: 3781-3790 [Abstract] [Full Text]
Lens, S. M. A., den Drijver, B. F. A., Potgens, A. J. G., Tesselaar, K., van Oers, M. H. J., van Lier, R. A. W. (1998). Dissection of Pathways Leading to Antigen Receptor-Induced and Fas/CD95-Induced Apoptosis in Human B Cells. J. Immunol. 160: 6083-6092 [Abstract] [Full Text]
Stohl, W., Elliott, J. E., Lynch, D. H., Kiener, P. A. (1998). CD95 (Fas)-Based, Superantigen-Dependent, CD4+ T Cell-Mediated Down-Regulation of Human In Vitro Immunoglobulin Responses. J. Immunol. 160: 5231-5238 [Abstract] [Full Text]
Saito, K., Sakurai, J., Ohata, J., Kohsaka, T., Hashimoto, H., Okumura, K., Abe, R., Azuma, M. (1998). Involvement of CD40 Ligand-CD40 and CTLA4-B7 Pathways in Murine Acute Graft-Versus-Host Disease Induced by Allogeneic T Cells Lacking CD28. J. Immunol. 160: 4225-4231 [Abstract] [Full Text]
Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N., Nagata, S. (1998). Transgenic Expression of Fas in T Cells Blocks Lymphoproliferation But Not Autoimmune Disease in MRL-lpr Mice. J. Immunol. 160: 3805-3811 [Abstract] [Full Text]
Schattner, E. J., Mascarenhas, J., Reyfman, I., Koshy, M., Woo, C., Friedman, S. M., Crow, M. K. (1998). Chronic Lymphocytic Leukemia B Cells Can Express CD40 Ligand and Demonstrate T-Cell Type Costimulatory Capacity. Blood 91: 2689-2697 [Abstract] [Full Text]
Plumas, J., Jacob, M.-C., Chaperot, L., Molens, J.-P., Sotto, J.-J., Bensa, J.-C. (1998). Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)-Mediated Apoptosis. Blood 91: 2875-2885 [Abstract] [Full Text]
Foote, L. C., Marshak-Rothstein, A., Rothstein, T. L. (1998). Tolerant B Lymphocytes Acquire Resistance to Fas-mediated Apoptosis after Treatment with Interleukin 4 but Not after Treatment with Specific Antigen Unless a Surface Immunoglobulin Threshold Is Exceeded. JEM 187: 847-853 [Abstract] [Full Text]
Gilfillan, M. C., Noel, P. J., Podack, E. R., Reiner, S. L., Thompson, C. B. (1998). Expression of the Costimulatory Receptor CD30 Is Regulated by Both CD28 and Cytokines. J. Immunol. 160: 2180-2187 [Abstract] [Full Text]
Wang, J., Lenardo, M. J. (1997). Essential Lymphocyte Function Associated 1 (LFA-1): Intercellular Adhesion Molecule Interactions for T Cell-mediated B Cell Apoptosis by Fas/APO-1/CD95. JEM 186: 1171-1176 [Abstract] [Full Text]
Yoshikawa, H., Sakihama, T., Nakajima, Y., Tasaka, K. (1997). Fcgamma RIII-Mediated Regulation of Hematopoiesis in Murine Bone Marrow Cells by Interleukin-3 and CD95 (Fas/Apo-1). Blood 90: 1911-1919 [Abstract] [Full Text]
Dilloo, D., Brown, M., Roskrow, M., Zhong, W., Holladay, M., Holden, W., Brenner, M. (1997). CD40 Ligand Induces an Antileukemia Immune Response In Vivo. Blood 90: 1927-1933 [Abstract] [Full Text]
Hirose, S., Yan, K., Abe, M., Jiang, Y., Hamano, Y., Tsurui, H., Shirai, T. (1997). Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune�elimination. Proc. Natl. Acad. Sci. USA 94: 9291-9295 [Abstract] [Full Text]
Genestier, L., Meffre, G., Garrone, P., Pin, J.-J., Liu, Y.-J., Banchereau, J., Revillard, J.-P. (1997). Antibodies to HLA Class I alpha 1 Domain Trigger Apoptosis of CD40-Activated Human B Lymphocytes. Blood 90: 726-735 [Abstract] [Full Text]
Landowski, T. H., Gleason-Guzman, M. C., Dalton, W. S. (1997). Selection for Drug Resistance Results in Resistance to Fas-Mediated Apoptosis. Blood 89: 1854-1861 [Abstract] [Full Text]
Tseng, J., Eisfelder, B. J., Clark, M. R. (1997). B-Cell Antigen Receptor-Induced Apoptosis Requires Both Igalpha and Igbeta. Blood 89: 1513-1520 [Abstract] [Full Text]
Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middelton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., Lenardo, M. J., Straus, S. E. (1997). Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis. Blood 89: 1341-1348 [Abstract] [Full Text]
Arimura, Y., Ogimoto, M., Mitomo, K., Katagiri, T., Yamamoto, K.-i., Volarevic, S., Mizuno, K., Yakura, H. (2001). CD45 Is Required for CD40-induced Inhibition of DNA Synthesis and Regulation of c-Jun NH2-terminal Kinase and p38 in BAL-17 B Cells. J. Biol. Chem. 276: 8550-8556 [Abstract] [Full Text]